glp 1 approved for type 1 diabetes GLP-1 drugs are all glucose control in 2 (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None Brand_PatchAid ADA: Tolerability questions linger Package Size:3-month supply

glp 1 approved for type 1 diabetes GLP-1 drugs are all glucose control in 2 (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None Brand_PatchAid ADA: Tolerability questions linger Package Size:3-month supply

ADA: Tolerability questions linger for Boehringer's obesity drug

PMID 15670850

Brand_PatchAid

Package Size:3-month supply

Indeed, on a global level, CKD is expected to become the fifth cause of death worldwide within 20 years, and diabetes-associated CKD is a key contributor to the increasing prevalence of CKD [5]